Judges Scientific (GB:JDG) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Judges Scientific has faced challenging trading conditions in the first half of 2024, with improvements anticipated in the second half. Despite a 4.2% increase in organic order intake year-to-date, the company now expects adjusted earnings per share to be between 270p and 300p, lower than previously forecasted. The board remains confident in the long-term growth prospects of the business.
For further insights into GB:JDG stock, check out TipRanks’ Stock Analysis page.
